-
Publisher Of
-
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Blood.
128:3083-3100.
2016
-
GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo.
Blood.
127:2723-2731.
2016
-
Cerebral Ischemia in Adults with Sickle Cell Disease after First Stroke.
Blood.
124.
2014
-
Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy.
Blood.
124.
2014
-
Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia.
Blood.
124.
2014
-
MEK Inhibitors, Novel Anti-Adhesive Molecules, Reverse Sickle Red Blood Cell Adhesion and Vaso-Occlusion in Vivo.
Blood.
124.
2014
-
Patent Foramen Ovale in Adult Patients with Sickle Cell Disease and Stroke.
Blood.
124.
2014
-
Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices.
Blood.
124.
2014
-
The DOT1L Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients with MLL-Rearranged Leukemia.
Blood.
124.
2014
-
The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications.
Blood.
124.
2014
-
Venous Thromboembolism (VTE) Surveillance: Incidence, Characteristics, and Initial Treatment of VTE Patients.
Blood.
124.
2014
-
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
Blood.
124:1915-1925.
2014
-
A Multicenter, Randomized, Dose Frequency Study of the Safety and Efficacy of Cerezyme (R) Infusions Every 4 Weeks Versus Every 2 Weeks in the Maintenance Therapy of Patients with Type 1 Gaucher Disease.
Blood.
112:460-460.
2008
-
A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies..
Blood.
112:350-350.
2008
-
Adherence with Hydroxyurea in Children with Sickle Cell Disease.
Blood.
112:69-69.
2008
-
Antecedent Transfusion and Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease..
Blood.
112:512-512.
2008
-
Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity.
Blood.
112:140-140.
2008
-
Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.
Blood.
112:1142-1142.
2008
-
Complications of Hysterectomy in Women with Von Willebrand Disease.
Blood.
112:1166-1166.
2008
-
Development of mPF4/Heparin Antibodies in a Murine Platelet Activation Model.
Blood.
112:106-107.
2008
-
Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.
Blood.
112:1118-1118.
2008
-
Does Living Closer to a Medical Care Center Matter in Sickle Cell Disease?.
Blood.
112:323-324.
2008
-
Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma.
Blood.
112:760-760.
2008
-
Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.
Blood.
112:685-686.
2008
-
Erythrocyte Adhesion and Phosphatidylserine Exposure in HbSC Disease: Baseline Data from the CHAMPS Study..
Blood.
112:861-861.
2008
-
Functional and Biochemical Changes in Stored Human Red Blood Cells.
Blood.
112:1355-1355.
2008
-
Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.
Blood.
112:785-786.
2008
-
Genomic Approaches to Identifying Risk for Pulmonary Artery Hypertension among Individuals with Sickle Cell Disease..
Blood.
112:514-514.
2008
-
Identification of Therapeutic Targets for Chronic Lymphocytic Leukemia in the Relapsed and Refractory Setting.
Blood.
112:720-720.
2008
-
Increased Hepcidin Expression in Mice Affected by beta-Thalassemia Reduces Iron Overload with No Effect on Anemia.
Blood.
112:53-53.
2008
-
Isolation and Expansion of Oligodendrocytes from Thawed, Cryopreserved Human Umblilical Cord Blood.
Blood.
112:1193-1193.
2008
-
MicroRNAs Distinguish Burkitt Lymphoma from the Molecular Subsets of Diffuse Large B Cell Lymphoma.
Blood.
112:1151-1151.
2008
-
MicroRNAs Regulate Mature B Cell Differentiation.
Blood.
112:262-262.
2008
-
Monocytes Are a Particularly Favorable Target for Surface Platelet Factor 4 (PF4) Antigenic Complex Formation in Heparin-Induced Thrombocytopenia: New Insights into the Thrombotic Risk in HIT.
Blood.
112:107-107.
2008
-
Obstetric and Gynecological History in Sickle Cell Disease Females.
Blood.
112:867-868.
2008
-
Plasmacytoid CD123+Dendritic Cell Recovery Is An Independent Predictor of Survival after Unrelated Cord Blood Transplant (UCBT).
Blood.
112:777-777.
2008
-
Prolonged Survival despite High Disease Burden in Elderly (>= 55) Patients with Hb SS or Hb S beta 0 Thalassemia.
Blood.
112:264-264.
2008
-
Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation.
Blood.
112:133-134.
2008
-
Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML.
Blood.
112:1019-1020.
2008
-
Risk factors for primary hemorrhagic stroke in adults with sickle cell disease.
Blood.
110:19B-20B.
2007
-
Bleeding.Events and other complications during pregnancy and childbirth in women with Von Willebrand disease..
Blood.
108:302A-302A.
2006
-
Blocking adhesion of sickle erythrocytes to endothelial alpha V beta 3 using RNA aptamer..
Blood.
108:206A-207A.
2006
-
Genetic polymorphisms associated with priapism in sickle cell disease..
Blood.
108:236A-237A.
2006
-
Role of A91V mutation in perforin gene in hemophagocytic lymphohistiocytosis.
Blood.
104:1910-1910.
2004
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood, bone marrow, and peripheral blood..
Blood.
98:321B-321B.
2001
-
Alemtuzumab (Campath) in relapsed or refractory CLL or PLL..
Blood.
98:290B-291B.
2001
-
Binding and uptake of PF4/heparin/antibody complexes in multiple cell types..
Blood.
98:35A-35A.
2001
-
Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment..
Blood.
98:104B-104B.
2001
-
Correction of Hurler Syndrome with unrelated umbilical cord blood transplantation..
Blood.
98:667A-667A.
2001
-
Cytokine modulation of inducible nitric oxide synthase (NOS2) mRNA levels and apoptosis in B-cell chronic lymphocytic leukemia (B-CLL): A quantitative analysis..
Blood.
98:362A-362A.
2001
-
Dose dense, high intensity therapy for mantle cell lymphoma..
Blood.
98:681A-682A.
2001
-
Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults..
Blood.
98:185A-185A.
2001
-
Enrichment of donor erythroid cells after non-myeloablative bone marrow transplantation (BMT) for sickle cell anemia (SCA)..
Blood.
98:490A-490A.
2001
-
Flow cytometric analysis in two large cohorts of patients with PNH..
Blood.
98:221A-221A.
2001
-
Functional T cell immunity before myeloid engraftment by donor post-thymic T cells in pediatric unrelated cord blood transplant recipients..
Blood.
98:379A-379A.
2001
-
High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc)..
Blood.
98:395B-395B.
2001
-
Impaired anticoagulant response to thrombin improves after regression of atherosclerosis in monkeys..
Blood.
98:257A-257A.
2001
-
Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response..
Blood.
98:236B-236B.
2001
-
J82 cell inositol polyphosphatide signaling via factor Xa and factor VIIa: The possible role of protease-activated receptor 2 (PAR-2) activation..
Blood.
98:53B-53B.
2001
-
Lack of standardization of methodology for enumeration of CD34 in banked umbilical cord blood..
Blood.
98:333B-333B.
2001
-
Low dose, weekly, paclitaxel as salvage therapy for non-Hodgkins lymphoma (NHL)..
Blood.
98:246B-246B.
2001
-
MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD..
Blood.
98:200A-200A.
2001
-
Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow..
Blood.
98:185A-185A.
2001
-
Molecular interaction of the Fanconi Anemia (FA) and Ataxia Telangiectasia (AT) pathways..
Blood.
98:782A-782A.
2001
-
Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population..
Blood.
98:853A-853A.
2001
-
Non-myeloablative allogeneic transplantation using T depleted matched sibling peripheral blood stem cells..
Blood.
98:420A-421A.
2001
-
Non-myeloablative transplantation using CAMPATH 1H for T depletion of mismatched, related donor peripheral blood stem cells..
Blood.
98:669A-669A.
2001
-
Phase I trial of prolonged infusion gemcitabine with fludarabine for relapsed/refractory acute leukemia..
Blood.
98:220B-221B.
2001
-
Prolonged infusion gemcitabine in combination with CPT-11 for relapsed or refractory hematologic malignancies..
Blood.
98:209B-209B.
2001
-
Radiolabeled anti-tenascin antibody for refractory non-Hodgkins lymphoma (NHL)..
Blood.
98:247B-247B.
2001
-
Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children..
Blood.
98:204A-204A.
2001
-
Red cell signaling pathways cause increased sickle cell adhesion to non-activated endothelial cells..
Blood.
98:484A-484A.
2001
-
Regulation of T and NK cell mediated cytotoxicity by the CD7 ligand, k12..
Blood.
98:23A-23A.
2001
-
Sickle red cell B-CAM/LU mediates adhesion to multiple sites of laminin under different conditions..
Blood.
98:484A-485A.
2001
-
The clinical course of PNH in the USA and in Japan..
Blood.
98:220A-220A.
2001
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
Blood.
98:687A-687A.
2001
-
alpha-adducin connects actin filament barbed ends to the platelet membrane skeleton..
Blood.
98:787A-787A.
2001
-
Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+cell count in cord blood: The COBLT experience..
Blood.
96:302B-302B.
2000
-
Banked umbilical cord blood is an excellent source of donor hematopoietic stem cells for infants with malignant and non-malignant conditions lacking a related donor..
Blood.
96:587A-+.
2000
-
Binding and activation of monocytes by PF4/heparin specific antibodies..
Blood.
96:269A-269A.
2000
-
Characterization of HLA polymorphism in an ethnically diverse cord blood bank..
Blood.
96:301B-301B.
2000
-
Cytokine regulation of inducible nitric oxide synthase (NOS2) and NOS2 inhibitor-induced apoptosis and death in chronic lymphocytic leukemia cells..
Blood.
96:159A-159A.
2000
-
Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) after high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected stem cell transplantation (SCT) for severe autoimmune diseases..
Blood.
96:406A-406A.
2000
-
Hematopoietic engraftment and survival after unrelated donor umbilical cord blood (UCB) transplantation in adult recipients..
Blood.
96:587A-+.
2000
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through Fc gamma RIIA..
Blood.
96:221A-221A.
2000
-
High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis (FEL)..
Blood.
96:362B-362B.
2000
-
High-dose immunosuppressive therapy (HDIT) and autologous stem cell transplant for severe systemic sclerosis (SSc)..
Blood.
96:844A-844A.
2000
-
Human erythrocyte and endothelial cells contain tissue transglutaminase that can regulates inflammation and platelet function by binding and releasing nitric oxide..
Blood.
96:38A-38A.
2000
-
In vivo behavior of factor IX and certain GLA domain mutants evaluated in coagulation factor M-deficient mice..
Blood.
96:35A-35A.
2000
-
Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis..
Blood.
96:57B-57B.
2000
-
Inverse relationship of plasma prostaglandin-E-2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria..
Blood.
96:31B-31B.
2000
-
Limitations of using CD23 expression by flow cytometry to differentiate mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma..
Blood.
96:330A-330A.
2000
-
Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (EBV-PTLD) in 263 unrelated donor umbilical cord blood transplant recipients..
Blood.
96:206A-206A.
2000
-
Nitric oxide as a nonprotein regulator of hematopoietic cell proliferation and differentiation-relationship to malarial anemia..
Blood.
96:14B-14B.
2000
-
Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank..
Blood.
96:206A-206A.
2000
-
Overexpression of anti-apoptosis genes in association with resistance to apoptosis observed in bone marrow failure syndromes..
Blood.
96:526A-526A.
2000
-
Oxygen-dependent export of nitric oxide from red blood cells..
Blood.
96:596A-+.
2000
-
Pediatric ALK-positive lymphomas coexpress c-Myc..
Blood.
96:128A-128A.
2000
-
Phase I trial of continuously infused gemcitabine with CPT-11 for refractory hematologic malignancies..
Blood.
96:216B-216B.
2000
-
Phase I trial of continuously infused gemcitabine with mitoxantrone for high risk or relapsed acute leukemia..
Blood.
96:326A-326A.
2000
-
Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia..
Blood.
96:385A-385A.
2000
-
Predictive value of day+50 immune reconstitution on the incidence of opportunistic infections and acute GVHD following unrelated cord blood transplants in children..
Blood.
96:789A-789A.
2000
-
Preliminary characterization of the surface staining of placental derived adherent cells: A potential new source of stroma for umbilical cord blood (UCB) expansion..
Blood.
96:150B-150B.
2000
-
Relationship between transferrin saturation and iron stores in US African-American and Caucasian populations..
Blood.
96:226A-226A.
2000
-
Serum alpha-2 macroglobulin (alpha 2M) determines NAT binding capacity in patients with peripheral vascular disease (PVD)..
Blood.
96:273A-273A.
2000
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
Blood.
96:842A-843A.
2000
-
Umbilical cord blood graft engineering using bone marrow stroma to enhance hematopoietic stem and progenitor cell content..
Blood.
96:774A-774A.
2000
-
Unrelated umbilical cord blood transplant for osteopetrosis..
Blood.
96:207A-207A.
2000
-
Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture..
Blood.
96:754A-754A.
2000
-
A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies..
Blood.
94:629A-629A.
1999
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood grafts and in recipients of unrelated umbilical cord blood transplants..
Blood.
94:326B-326B.
1999
-
Acute lymphoblastic leukemia in infancy: Improved outcome with unrelated placental cord blood (PCB) transplants..
Blood.
94:712A-712A.
1999
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expaned cells, a phase I trial using the replicell system..
Blood.
94:571A-571A.
1999
-
Characterization of a monoclonal antibody to PF4/heparin (KKO) with functional and serologic properties of hit antibodies..
Blood.
94:21A-21A.
1999
-
Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation for mucopolysaccharidosis type 6: Report of 3 cases..
Blood.
94:334A-335A.
1999
-
Evaluation of thalidomide for the treatment of chronic graft-versus-host disease in "high risk" patients..
Blood.
94:158A-158A.
1999
-
Human platelet adducin: A regulated actin filament barbed end-capping protein..
Blood.
94:216A-216A.
1999
-
Inducible nitric oxide synthase (NOS2) inhibitors induce high level CLL cell apoptosis and death..
Blood.
94:703A-703A.
1999
-
Laminin binding and B-CAM/LU expression by high and low density reticulocytes vs mature red cells in sickle cell disease..
Blood.
94:675A-675A.
1999
-
Manipulation of CD22 signal transduction for the treatment of lymphoma..
Blood.
94:93A-93A.
1999
-
Markers of angiogenesis, factor VIII and tenascin, correlate with disease activity in patients with Non-Hodgkin's Lymphoma..
Blood.
94:253B-253B.
1999
-
Stable mixed chimerism after bone marrow transplantation (BMT) for Sickle Cell Disease (SCD)..
Blood.
94:645A-645A.
1999
-
Stroma from adult bone marrow increases the productivity of ex vivo cord blood expansion cultures..
Blood.
94:164B-164B.
1999
-
The effect of cytokine combinations on the clinical scale ex-vivo expansion of umbilical cord blood..
Blood.
94:573A-573A.
1999
-
Transplantation of a patient with congenital neutropenia and invasive fungal disease with unrelated umbilical cord blood using paternal G-CSF mobilized, irradiated granulocyte support..
Blood.
94:368B-369B.
1999
-
Unrelated umbilical cord blood transplants in adult patients (pts) with hematologic malignancies or genetic disorders..
Blood.
94:570A-570A.
1999
-
The oncogenic E2A-HLF fusion protein protects leukemic B-precursor cells from apoptosis..
Blood.
86:1297-1297.
1995
-
SUCCESSFUL TREATMENT (RX) OF PATIENTS (PTS) WITH REFRACTORY SEVERE APLASTIC-ANEMIA (SAA) WITH CONCOMITANT CYCLOSPORINE (CSA) AND COLONY-STIMULATING FACTORS (CSF).
Blood.
84:A10-A10.
1994
-
A Role for the CRM1 Nuclear Export Receptor in HOXA Gene Deregulation and CALM-AF10Leukemogenesis.
Blood.
2017
-
Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data.
Blood.
2017
-
Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey.
Blood.
2017
-
Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia.
Blood.
2017
-
Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP.
Blood.
2017
-
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differentiation Following Sy-1425 Treatment.
Blood.
2017
-
Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens.
Blood.
2017
-
Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow.
Blood.
2017
-
Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs.
Blood.
2017
-
IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Blood.
2017
-
Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA).
Blood.
2017
-
Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study.
Blood.
2017
-
Multiple Myeloma Symptom Burden, Perceived Control, and Quality of Life: Findings from the Cancer Experience Registry.
Blood.
2017
-
PD-L1 Expression and Gene Amplification in CD30+Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics.
Blood.
2017
-
Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors.
Blood.
2017
-
Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults.
Blood.
2017
-
Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia.
Blood.
2017
-
Pre-Transfusion Rejuvenation of RBCs for Red Blood Cell Exchange: Report of Feasibility.
Blood.
2017
-
Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study.
Blood.
2017
-
Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History.
Blood.
2017
-
Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib.
Blood.
2017
-
Results from the US Life after Stopping TKIs (LAST) Study.
Blood.
2017
-
Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect.
Blood.
2017
-
The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation.
Blood.
2017
-
Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period.
Blood.
2017
-
Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia.
Blood.
2017
-
Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices.
Blood.
2017
-
Cell-Free DNA Is Elevated after Acute Arterial Injury in Infants.
Blood.
2016
-
Three Factor Prothrombin Complex Concentrates in Cardiac Surgery: A Novel Algorithmic Approach to Perioperative Bleeding.
Blood.
2016
-
A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition.
Blood.
2015
-
A Phase 1 Trial of SGN-CD33A As Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia (AML).
Blood.
2015
-
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies.
Blood.
2015
-
AAV Gene Therapy for MPS1 Corneal Clouding and Joint Stiffness.
Blood.
2015
-
Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117.
Blood.
2015
-
Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study.
Blood.
2015
-
Autologous Cord Blood Infusion for the Treatment of Brain Injury in Children with Cerebral Palsy.
Blood.
2015
-
Baseline Predictors of Mortality in Patients with Relapsed or Refractory Acute Myeloid Leukemia Treated with Vosaroxin Plus Cytarabine or Placebo Plus Cytarabine in the Phase 3 VALOR Study.
Blood.
2015
-
Cord Blood Unit Cryopreservation: Positioning Segments for Potency Assessment.
Blood.
2015
-
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial.
Blood.
2015
-
Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106.
Blood.
2015
-
Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma.
Blood.
2015
-
Dickkopf 1 (Dkk1) Regulates Hematopoietic Stem Cell Regeneration.
Blood.
2015
-
ENESTnext Final Results: Deep Molecular Response (MR) with Nilotinib (NIL) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
Blood.
2015
-
Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi Institutional Review.
Blood.
2015
-
Effect of Minimal Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia.
Blood.
2015
-
Functional Analysis of the CML Blast Crisis Transcriptome and Epigenome Using Crispr-CAS9 and Pharmacologic Approaches.
Blood.
2015
-
Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy.
Blood.
2015
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell (HSC) Self-Renewal Via Control of mTOR Signaling.
Blood.
2015
-
Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone.
Blood.
2015
-
Impact of Available Therapies on Survival of Very Elderly Myelodysplastic Syndrome (MDS) Patients (Age above 75 yrs).
Blood.
2015
-
Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission.
Blood.
2015
-
Lead-in Stage Results of a Pivotal Trial of SL-401, an Interleukin-3 Receptor (IL-3R) Targeting Biologic, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) or Acute Myeloid Leukemia (AML).
Blood.
2015
-
Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML).
Blood.
2015
-
Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants.
Blood.
2015
-
North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia.
Blood.
2015
-
Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit.
Blood.
2015
-
Potentially Avoidable Hospitalizations in Older Patients with Acute Myeloid Leukemia (AML).
Blood.
2015
-
Prognostic Methylation Markers for Survival in Cytogenetically Normal AML Patients Treated on SWOG Trials.
Blood.
2015
-
Prothrombin Complex Concentrates and Cardiac Surgery.
Blood.
2015
-
Rapid Achievement of MR4.5 after Switching from Imatinib (IM) to Nilotinib (NIL) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Preliminary Results from ENESTgoal.
Blood.
2015
-
Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306.
Blood.
2015
-
Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia.
Blood.
2015
-
SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML.
Blood.
2015
-
Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study.
Blood.
2015
-
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia.
Blood.
2015
-
Targeting the Human Notch 2-BCR Axis: A Driver of B-Cell Hyper-Responsiveness in Active Chronic Graft-Versus Host Disease (cGVHD).
Blood.
2015
-
The Phenotypic Spectrum of Pyruvate Kinase Deficiency (PKD) from the PKD Natural History Study (NHS): Description of Four Severity Groups By Anemia Status.
Blood.
2015
-
The Thrombotic Microangiopathy Registry of North America.
Blood.
2015
-
Thrombocytopenia in Hospitalized Non-ICU Patients.
Blood.
2015
-
beta-arrestin2 Is Necessary for Development of MPLW515L Mutant Primary Myelofibrosis.
Blood.
2015
-
A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis.
Blood.
2014
-
A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117.
Blood.
2014
-
Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation.
Blood.
2014
-
Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood.
2014
-
Atomic Level Description of the Immune Complex That Causes Heparin-Induced Thrombocytopenia (HIT).
Blood.
2014
-
Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease.
Blood.
2014
-
Broncho-Alveolar Lavage and Lung Biopsy in Patients with Hematological Malignancy and Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review and Meta-Analysis.
Blood.
2014
-
Calcium Calmodulin Dependent Kinase Kinase 2 Regulates Hematopoietic Stem Cell Regeneration and Quiescence.
Blood.
2014
-
Clinical and Biological Features of Primary Testicular B-Cell Lymphoma - a Single-Institution Study of 89 Cases.
Blood.
2014
-
Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study.
Blood.
2014
-
Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update.
Blood.
2014
-
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival.
Blood.
2014
-
Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification.
Blood.
2014
-
Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia.
Blood.
2014
-
Effects of Sulforaphane Obtained from Broccoli Sprout Homogenate in Patients with Sickle Cell Disease (SCD).
Blood.
2014
-
Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG.
Blood.
2014
-
Epigenetics of Cellular Memory: Insights from the Chromatin Accessibility Landscape of the Mitotic Genome.
Blood.
2014
-
Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model.
Blood.
2014
-
Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL).
Blood.
2014
-
Genes Associated with Alloimmunization to Blood Group Antigens in Sickle Cell Disease.
Blood.
2014
-
Genes Associated with Survival in Adult Sickle Cell Disease.
Blood.
2014
-
Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients.
Blood.
2014
-
Growing Pains - Determination of Transfer and Transition from Pediatrics to Adult Outpatient Clinics for Patients with Sickle Cell Disease (SCD).
Blood.
2014
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell Renewal.
Blood.
2014
-
Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR).
Blood.
2014
-
Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML).
Blood.
2014
-
Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer.
Blood.
2014
-
NF-kappa B Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood.
2014
-
Outcomes Following Allogeneic Stem Cell Transplantation (AlloSCT) in Patients with Primary Mediastinal (PMBL), Germinal Center B (GCB) and Non-GCB Cell-like Diffuse Large B Cell Lymphomas (DLBCL).
Blood.
2014
-
Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial.
Blood.
2014
-
Phase II study of (90)y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma.
Blood.
2014
-
Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience.
Blood.
2014
-
Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope (TM)): Case Matched Analysis.
Blood.
2014
-
Protein Tyrosine Phosphatase-Sigma (PTP sigma) Regulates Hematopoietic Stem Cell Repopulating Capacity.
Blood.
2014
-
The CRM1 Nuclear Export Receptor Activates HOXA Gene Expression in Leukemogenesis.
Blood.
2014
-
Understanding the Underlying Immune Response in HIT: Uptake of PF4/Heparin Complexes By Monocytes & Dendritic Cells.
Blood.
2014
-
X-Ray Structure of an Anticoagulant RNA Aptamer Bound to Factor Xa. Structural Basis for Its Ability to Disrupt Interactions Between Xa and Va within Prothrombinase.
Blood.
2014
-
Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance).
Blood.
3903-3906.
2013
-
MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program.
Blood.
2013
-
NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals.
Blood.
2013
-
STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program.
Blood.
2013
-
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502.
Blood.
2012
-
Genetic Loss of Tmprss6 Increases Effective Erythropoiesis in a Mouse Model of beta-Thalassemia.
Blood.
2012
-
Modeling Variation in the Human Lymphoma Microenvironment with the E mu-Myc Mouse Model.
Blood.
2012
-
No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial.
Blood.
2012
-
Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation.
Blood.
2012
-
Therapeutic Benefit of Small Molecule Inhibitors of MEK/ERK in Reducing Sickle Red Cell Adhesion and Vaso-Occlusion in Vivo.
Blood.
2012
-
A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia.
Blood.
724-724.
2011
-
A Phase II Prospective Feasibility Study of Clofarabine Cytoreduction Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed or Refractory Acute Leukemias and Advanced Myelodysplastic Syndromes.
Blood.
231-232.
2011
-
A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response.
Blood.
666-667.
2011
-
ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet 'Favorable' Genetic Category.
Blood.
192-192.
2011
-
An Elevated Tricuspid Regurgitant Jet Velocity in Sickle Cell Disease Is Associated with Polymorphisms in Genes Impacting Innate Immunity.
Blood.
240-240.
2011
-
Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease.
Blood.
931-932.
2011
-
CALM Insufficiency Impairs Leukemia Cell Proliferation by Limiting Iron Uptake.
Blood.
642-642.
2011
-
CPX-351: A Randomized Phase 2b Study of CPX-351 v. Intensive Salvage Therapy in '65 Yo First Relapse AML Patients: Initial Efficacy and Safety Report.
Blood.
116-116.
2011
-
Characterization of Pim Protein Kinases and Evaluation of Small Molecule Inhibitors in Multiple Myeloma.
Blood.
1254-1255.
2011
-
Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost.
Blood.
1729-1729.
2011
-
Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells.
Blood.
132-133.
2011
-
Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol.
Blood.
226-227.
2011
-
Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends.
Blood.
839-840.
2011
-
Genomic Heterogeneity in B-Cell Malignancies.
Blood.
1480-1480.
2011
-
HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery.
Blood.
524-525.
2011
-
High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma.
Blood.
1152-1152.
2011
-
High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation.
Blood.
879-879.
2011
-
Hijacking the Niche: The Role of Stromal Osteopontin in the Induction of Leukemic Dormancy within the Bone Marrow Microenvironment.
Blood.
342-343.
2011
-
Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.
Blood.
1765-1765.
2011
-
Inflammatory Polymorphisms Link the Risk of Acute Chest Syndrome with Asthma in Adults with Sickle Cell Disease.
Blood.
493-493.
2011
-
MiR-3151, a Novel MicroRNA Embedded in BAALC, Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML).
Blood.
635-635.
2011
-
Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy.
Blood.
469-469.
2011
-
Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures.
Blood.
1476-1477.
2011
-
Prevalence of MBL Increases Over Time In Relatives of CLL Families.
Blood.
1659-1659.
2011
-
Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18-60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG.
Blood.
1080-1080.
2011
-
Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts).
Blood.
190-191.
2011
-
Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia.
Blood.
778-779.
2011
-
Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia.
Blood.
1532-1533.
2011
-
Referral Patterns and Outcomes for Women with for Recurrent Pregnancy Loss Managed At a Multidisciplinary Thrombosis Program.
Blood.
1792-1793.
2011
-
Relationships Among Commonly Used Measures of Cord Blood Potency, ALDH(br) Cell Content, and Colony Forming Cell Content in Cord Blood Units Prior to Cryopreservation: Towards An Improved Metric for Potency of Banked Cord Blood.
Blood.
1731-1732.
2011
-
Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia.
Blood.
348-348.
2011
-
Safety and Tolerability of Plerixafor in Combination with Cytarabine and Daunorubicin in Patients with Newly Diagnosed Acute Myeloid Leukemia-Preliminary Results From a Phase I Study.
Blood.
39-40.
2011
-
Significance of Prior HSCT on the Outcome of Salvage Therapy with CPX-351 or Conventional Chemotherapy Among First Relapse AML Patients.
Blood.
1125-1125.
2011
-
Sirolimus Inhibits Proliferation but Enhances Suppressive Activity of Rhesus Macaque Natural CD4 Regulatory T Cells.
Blood.
461-461.
2011
-
Tandem HLA-Mismatched Cadaveric Unrelated Donor Lung Transplant Followed by CD3-and CD19-Depleted Bone Marrow Transplant From the Same Donor Permits Withdrawal of Systemic Immunosuppression with Graft Acceptance and Functional Immune Reconstitution.
Blood.
460-461.
2011
-
The Impact of Factor IX Level on Thrombin Generation and Bleeding During Warfarin Anticoagulation.
Blood.
250-250.
2011
-
The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation.
Blood.
1736-1736.
2011
-
The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome.
Blood.
1229-1229.
2011
-
The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study.
Blood.
433-434.
2011
-
Transient Decrease in Factor VIII Following Delivery: Clearance or Consumption?.
Blood.
992-993.
2011
-
What Clinical Characteristics of Mothers and Babies Favorably Influence Cord Blood Potency? Defining Parameters That Can Guide Public Cord Blood Collection.
Blood.
225-226.
2011
-
Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma.
Blood.
199-200.
2011
-
Whole-Exome Sequencing Identifies Novel Risk Variant for Thrombotic Storm.
Blood.
552-552.
2011
-
A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study.
Blood.
1636-1636.
2010
-
A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation.
Blood.
954-955.
2010
-
A Novel Scoring System, the Cord Blood Apgar, Predicts Engraftment After Cord Blood Transplantation: Optimization of Selection of Cord Blood Units (CBUs) for Transplantation.
Blood.
158-158.
2010
-
A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies.
Blood.
1349-1350.
2010
-
A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease.
Blood.
1321-1321.
2010
-
A Retrospective Multi-Center Analysis of Prognostic Factors Determining Outcomes In Patients with Secondary AML..
Blood.
883-884.
2010
-
ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.
Blood.
9-10.
2010
-
Allogeneic Effector Memory T Cells Enhance Hematopoietic Engraftment and Immune Reconstitution After Stem Cell Transplantation.
Blood.
41-41.
2010
-
Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma.
Blood.
351-352.
2010
-
An Ear-Tissue Model for High-Resolution In Vivo Imaging..
Blood.
623-623.
2010
-
Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study.
Blood.
237-238.
2010
-
Anti-Inflammatory Markers Are Associated with Glomerular Filtration Rate In Adults with Sickle Cell Disease.
Blood.
693-694.
2010
-
Atypical Activation of Plasma Membrane-Bound ERK1/2 Is Associated with Regulation of Sickle Red Cell Adhesion to Endothelium.
Blood.
122-122.
2010
-
Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia.
Blood.
98-99.
2010
-
Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol.
Blood.
399-400.
2010
-
Dendritic Cell Activation by PF4/H Multimolecular Complexes.
Blood.
318-319.
2010
-
Disruption of PF4/Hep Multimolecular Complex Assembly Using a Minimally Anticoagulant Heparin (ODSH).
Blood.
319-319.
2010
-
Donor Cell Leukemia: A Clinicopathological Study of 9 Cases and a Comprehensive Review of Literature.
Blood.
1423-1424.
2010
-
Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil (R)) plus G-CSF In Adult Patients with Non-Hematologic Malignancies..
Blood.
925-925.
2010
-
Efficacy and Toxicity of Rituximab and Brief Duration, High Intensity Chemotherapy with Filgrastim Support for Burkitt or Burkitt - Like Leukemia/Lymphoma: Cancer and Leukemia Group B (Calgb) Study 10002.
Blood.
374-375.
2010
-
Efficacy of Denileukin Diftitox Retreatment In Patients with Cutaneous T-Cell Lymphoma Who Relapsed After Initial Response.
Blood.
1179-1179.
2010
-
Facilitation of Hematopoietic Reconstitution Via Inhibition of Bone Marrow Endothelial Cell-Mediated SDF-1 Signaling.
Blood.
1578-1578.
2010
-
Factors Associated with Heterocellular Aggregate Formation In Sickle Cell Disease..
Blood.
1101-1101.
2010
-
GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease..
Blood.
685-686.
2010
-
Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy.
Blood.
692-692.
2010
-
Heparin Modifies the Immunogenicity of Positively-Charged Proteins.
Blood.
615-616.
2010
-
Hepcidin as a Therapeutic Tool to Limit Iron Overload and Improve Anemia In beta-Thalassemia.
Blood.
443-444.
2010
-
Hydroxyurea Reduces Conversion From Conditional to Abnormal TCD Velocities In Children with Sickle Cell Anemia (SCA).
Blood.
123-124.
2010
-
Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach.
Blood.
119-119.
2010
-
Identification of a Costimulation Blockade Resistant Mechanism of Bone Marrow Allograft Rejection Induced by Infection with a Murine EBV Homologue..
Blood.
625-625.
2010
-
Increased Platelet Binding of NN1731, a Factor VIIa Variant with Enhanced Tissue Factor-Independent Activity.
Blood.
491-491.
2010
-
Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes.
Blood.
1100-1100.
2010
-
Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci.
Blood.
1014-1014.
2010
-
Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning.
Blood.
120-120.
2010
-
Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).
Blood.
1430-1431.
2010
-
Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study.
Blood.
48-49.
2010
-
Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control.
Blood.
639-640.
2010
-
Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.
Blood.
1168-1169.
2010
-
Phase I Trial Results for SL-401, a Novel Cancer Stem Cell (CSC) Targeting Agent, Demonstrate Clinical Efficacy at Tolerable Doses In Patients with Heavily Pre-Treated AML, Poor Risk Elderly AML, and High Risk MDS.
Blood.
1351-1351.
2010
-
Pleiotrophin Signaling Is Necessary and Sufficient for Hematopoietic Stem Cell Self-Renewal In Vivo.
Blood.
180-180.
2010
-
Post-Transplant Lymphoproliferative Disease In Liver Transplant Recipients: A Single Institution Experience.
Blood.
731-731.
2010
-
Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).
Blood.
768-769.
2010
-
Pregnancy In Type 1 Von Willebrand Disease: A Prospective Study of VWF Levels and Risk Factors for Bleeding..
Blood.
606-606.
2010
-
Prolonged Administration of Azacitidine with or without Entinostat Increases Rate of Hematologic Normalization for Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905.
Blood.
264-265.
2010
-
Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies..
Blood.
1456-1457.
2010
-
Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd..
Blood.
1453-1454.
2010
-
Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation.
Blood.
104-105.
2010
-
Relationship of Soluble Adhesion Receptors to Red Cell Apoptosis In SCD.
Blood.
694-694.
2010
-
Resource Use and Expenditures Among Adult Sickle Cell Patients with and without Depression..
Blood.
653-653.
2010
-
S-Nitrosylation of Rap1and Relationship to Rap1 Activity and Disease Status In SCD.
Blood.
1098-1098.
2010
-
Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa..
Blood.
603-603.
2010
-
Targeting Destruction of Mcl-1 by Activation of Protein Phosphatase 2A In CLL and B-Cell Lymphomas.
Blood.
1703-1704.
2010
-
The Molecular Profile of Richter Syndrome Predicts Survival From Transformation: The Role of Clonal Relationship.
Blood.
1482-1482.
2010
-
The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study.
Blood.
288-288.
2010
-
The Serine Protease Tmprss6 Regulates Hepcidin Expression, but Its Loss Does Not Cause Systemic Iron Deficiency In the Fetal and Neonatal Periods.
Blood.
1728-1728.
2010
-
Tmprss6, An Inhibitor of Hepatic Bmp/Smad Signaling, Is Required for Hepcidin Suppression and Iron Loading In a Mouse Model of beta-Thalassemia.
Blood.
75-75.
2010
-
Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing-Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis.
Blood.
482-483.
2010
-
VE Cadherin Positive Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo.
Blood.
1532-1532.
2010
-
Validation of the Cord Blood (CB) APGAR Score System to Predict Neutrophil Engraftment of Plasma Depleted CB Products.
Blood.
1459-1460.
2010
-
A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies.
Blood.
948-949.
2009
-
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia.
Blood.
918-918.
2009
-
A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML..
Blood.
431-431.
2009
-
ALDH(br) Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation..
Blood.
960-961.
2009
-
Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.
Blood.
1205-1205.
2009
-
Allospecific Effector Memory T Cells Are Able to Mediate Second-Set Skin Graft Rejection but Unable to Induce Graft-Versus-Host Disease.
Blood.
100-100.
2009
-
Cenersen, An Antisense Inhibitor of p53, in Combination with Fludarabine, Cyclophosphamide, and Rituximab Shows Clinical Activity in High Risk CLL..
Blood.
1332-1332.
2009
-
Characterization of Receptors Involved in Heparin Antibody Complex Mediated Induction of Tissue Factor Expression in Monocytes.
Blood.
97-98.
2009
-
Comparison of Thrombin Generation of Sickle Cell Patients in Microparticle Rich and Microparticle Poor Plasma Using Thrombin Generation Assay (TGA)..
Blood.
1004-1004.
2009
-
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors.
Blood.
814-814.
2009
-
Creation of a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Cord Blood Potency..
Blood.
1246-1247.
2009
-
Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.
Blood.
272-273.
2009
-
Deletion of Bak and Bax in Tie2+BM Hematopoietic Stem Cells Induces a B Cell Lymphoproliferative Disorder.
Blood.
513-513.
2009
-
Development of a Decision Support Tool to Guide Management of Adults with Sickle Cell Disease: The Emergency Department Sickle Cell Assessment of Strengths and Needs (ED-SCANS)..
Blood.
575-576.
2009
-
Effect of PAI-1 Specific RNA Aptamers On Cell Adhesion and Motility.
Blood.
840-840.
2009
-
Effects of Hydroxyurea (HU) and Magnesium Pidolate (Mg) in Hemoglobin SC Disease (HbSC): the "CHAMPS" Trial.
Blood.
338-338.
2009
-
Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
Blood.
1272-1273.
2009
-
Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.
Blood.
511-511.
2009
-
Genome-Wide Analysis of Microdeletions and Identification of NF1 Inactivation in Acute Myelogenous Leukemia..
Blood.
73-74.
2009
-
Genome-Wide Studies in Sickle Cell Anemia Show Associations Between SNPs in the Olfactory Receptor Gene Cluster and Fetal Hemoglobin Concentration.
Blood.
339-339.
2009
-
Heparin Forms Macromolecular Complexes with Protamine and Lysozyme..
Blood.
538-539.
2009
-
Histone Deacetylase Inhibition Using LBH589 Is Effective in Lymphoma and Results in Down-Regulation of the NF-KB Pathway.
Blood.
1436-1437.
2009
-
Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm.
Blood.
980-980.
2009
-
Impact of Nucleated Cell Dose On Engraftment and Survival After Unrelated Cord Blood Transplantation for Severe Aplastic Anemia: A Retrospective Study On Behalf of Eurocord and the EBMT SAA WP.
Blood.
1240-1241.
2009
-
Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
Blood.
866-867.
2009
-
In-Hospital Outcomes Among Sickle Cell Patients with Acute Chest Syndrome: Results From a National Database..
Blood.
557-557.
2009
-
Increased Severity of Pandemic H1N1 Influenza in Children and Young Adults with Sickle Cell Disease.
Blood.
112-112.
2009
-
Influence of Statin Therapy On the Clinical Course of Chronic Lymphocytic Leukemia.
Blood.
926-926.
2009
-
Long-Term Survival and Late Deaths After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism.
Blood.
1287-1288.
2009
-
Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT).
Blood.
193-193.
2009
-
Low Levels of Apolipoprotein A1 Are Associated with Silent Cerebral Infarets in Children with Sickle Cell Disease.
Blood.
109-110.
2009
-
Maintenance Therapy with Low-Dose Subcutaneous 5-Azacitidine in Older Patients with AML in 1st Remission..
Blood.
425-426.
2009
-
Molecular Profiling Identifies Plasmablasts as the Cells of Origin of Activated Diffuse Large B Cell Lymphoma.
Blood.
257-257.
2009
-
Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials).
Blood.
1277-1277.
2009
-
Overexpression and Phosphorylation of eIF4E Is Required for Beta-Catenin Activation in Blast Crisis Chronic Myelogenous Leukemia.
Blood.
22-22.
2009
-
Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study..
Blood.
457-458.
2009
-
Physiologic Hypoxia Protects Chronic Myelogenous Leukemia Progenitors From Elimination by Imatinib Mesylate.
Blood.
858-858.
2009
-
Plerixafor (Mozobil (R)) Selectively Enhances Donor Hematopoietic Cell Engraftment.
Blood.
155-155.
2009
-
Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL)..
Blood.
669-669.
2009
-
Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia.
Blood.
326-327.
2009
-
Prevention of Acute GvHD During MHC Haploidentical BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model..
Blood.
968-969.
2009
-
Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.
Blood.
1012-1013.
2009
-
Racial Differences in Thrombotic Risk Factors Associated with Adverse Pregnancy Outcome Among Women Obtaining Care in US Thrombosis and Hemostasis Centers.
Blood.
1164-1164.
2009
-
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.
Blood.
325-326.
2009
-
Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death..
Blood.
613-614.
2009
-
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who Are >= 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors.
Blood.
822-823.
2009
-
The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells.
Blood.
931-931.
2009
-
The Complex Relationship Between Sickle Cell Disease and Depression.
Blood.
1014-1015.
2009
-
Thienopyridine-Associated Thrombotic Thrombocytopenia Purpura: Updated Antibody Results From the SERF-TTP Study.
Blood.
367-368.
2009
-
Thymic Recovery and De Novo T Cell Production During the First Year After Unrelated Cord Blood Transplant (UCBT) Predicts Overall Survival: A Multivariate Analysis of 93 Patients Following Myeloablative Conditioning and a Single Unit Graft..
Blood.
481-482.
2009
-
Tie2+Bone Marrow Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo.
Blood.
106-106.
2009
-
Tmprss6 Is a Genetic Modifier of the Hfe-Hemochromatosis Phenotype in Mice.
Blood.
259-259.
2009
-
Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.
Blood.
1319-1319.
2009
-
Use of Aldehyde Dehydrogenase Content to Predict Dominating Cord in Double Cord Blood Transplant.
Blood.
847-848.
2009
-
Use of a Computer Based Neurocognitive Software Program in Asymptomatic Neurologically Intact Adults with Sickle Cell Disease..
Blood.
612-612.
2009
-
Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study.
Blood.
181-181.
2008
-
Comprehensive Ultra High Resolution Analysis of Copy Number and Allele Status Including Novel Microdeletions Spanning NF1 in Acute Myelogenous Leukemia.
Blood.
1066-1066.
2008
-
Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.
Blood.
800-800.
2008
-
Durable Responses in Patients Treated with Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory Follicular Lymphoma: Long-Term Follow-up of a Phase II Clinical Trial..
Blood.
369-370.
2008
-
Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy.
Blood.
474-475.
2008
-
Identification of p53 Aberration-Dependent as Well as Non-p53-Mediated Resistance to MDM2 Inhibitors in Acute Myelogenous Leukemia.
Blood.
569-569.
2008
-
Insulin-Like Growth Factor 1 Protects against Lethal Irradiation..
Blood.
1196-1196.
2008
-
Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.
Blood.
749-749.
2008
-
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy.
Blood.
209-209.
2008
-
Prevention of Acute GvHD during Haplo-BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model.
Blood.
1207-1207.
2008
-
Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.
Blood.
690-690.
2008
-
Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Blood.
833-833.
2008
-
Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study.
Blood.
340-341.
2008
-
A conditional risk model for chemotherapy-induced anemia (CIA) in cancer patients..
Blood.
117A-117A.
2007
-
Avoidance of post-thaw wash prior to transplantation of plasma depleted cord blood (PD CB) is associated with improved engraftment & decreased severity of chronic GvHD (cGvHD) without increased relapse.
Blood.
494A-494A.
2007
-
Blocking adhesion of sickle erythrocytes to endothelial P-selectin using an RNAaptamer.
Blood.
51A-51A.
2007
-
Clinical and outcomes findings for thrombotic thrombocytopenic purpura among 467 persons with severely versus not severely deficient ADAMTS13 levels.
Blood.
622A-622A.
2007
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
Blood.
73A-73A.
2007
-
Further investigation of the role of factor XIII in priapism associated with SCD.
Blood.
998A-998A.
2007
-
Genomic complexity identifies patients with agressive chronic lymphocytic leukemia..
Blood.
151A-151A.
2007
-
Inhibition of nitric oxide synthase (NOS) 1, NOS2, and NOS3 enzymatic activities by vitamin B-12 and related corrins: Biochemical and molecular modeling studies.
Blood.
783A-783A.
2007
-
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 with differential expression of LATS2.
Blood.
617A-617A.
2007
-
Sickle RBCs stimulate human monocyte cytokine expression.
Blood.
668A-669A.
2007
-
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-incluced mobilization.
Blood.
72A-72A.
2007
-
The relationship of opiate analgesia to quality of life in an adult sickle cell population.
Blood.
670A-670A.
2007
-
Changes in the pattern of cytogenetic aberrations with advancing age in acute myeloid (Non-APL) leukemia: A Southwest Oncology study (S9007)..
Blood.
242A-242A.
2006
-
Coagulopathy from severe postpartum hemorrhage..
Blood.
116B-116B.
2006
-
Current prevalence of specific clinical outcomes in adult patients with HbSS or Hb S beta(0) thalassemia..
Blood.
353A-353A.
2006
-
Defects in E2F1/2 expression are associated with abnormalities in cell cycle and differentiation in EKLF-deficient erythroid cells..
Blood.
29A-29A.
2006
-
Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial..
Blood.
17A-18A.
2006
-
Determinants of PF4/heparin immunogenicity in a murine model of HIT..
Blood.
32A-33A.
2006
-
Effect of single dose in vivo propranolol therapy on in vitro adhesion of human SS RBC..
Blood.
363A-363A.
2006
-
Impaired maturation and survival of T lymphocytes, B lymphocytes, and NK cells in mice lacking Gimap5/Ian5..
Blood.
276A-276A.
2006
-
Interaction of activated sickle red cell LW with leukocytes induces leukocyte adhesion to endothelium via CD44-E-selectin..
Blood.
361A-361A.
2006
-
MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL..
Blood.
556A-557A.
2006
-
Mechanism of soluble laminin-mediated enhancement of sickle red cell adhesion to endothelial cells..
Blood.
364A-364A.
2006
-
Preliminary results from the surveillance, epidemiology & risk factors for TTP (SERF-TTP) group: A prospective case-control study of idiopathic TTP..
Blood.
316A-317A.
2006
-
Prospective validation of a predictive model for early anemia in patients receiving cancer chemotherapy..
Blood.
140A-140A.
2006
-
Restoring initial thrombin generation does not normalize cutaneous wound healingin hemophilia B..
Blood.
306A-306A.
2006
-
Role of erythropoietin as an angiogenic factor and target in cancer..
Blood.
127A-127A.
2006
-
Unrelated donor hematopoietic stem cell transplantation (HSCT) in children with acute leukemia: Risks and benefits of umbilical cord blood (CB) versus HLAA, B, C, DRB1 allele-matched bone marrow (BM)..
Blood.
133A-133A.
2006
-
A differentiation block in erythroid cells lacking erythroid krupple-like factor (EKLF)..
Blood.
157A-157A.
2005
-
A phase 2 clinical trial of AP23573, an mTOR inhibitor, In patients with relapsed or refractory hematologic malignancies.
Blood.
835A-836A.
2005
-
A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma..
Blood.
379B-379B.
2005
-
A randomized, open-label study of Lestaurtinib (CEP-701), an oral FLT3 inhibitor, administered in sequence with chemotherapy in patients with relapsed AML harboring FLT3 activating mutations: Clinical response correlates with successful FLT3 inhibition..
Blood.
121A-121A.
2005
-
A report of the event free survival (EFS) for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) treated on pediatric oncology group (POG) protocol 9605..
Blood.
257A-257A.
2005
-
A report of the event-free survival (EFS) and neurotoxicity for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) on pediatric oncology group (POG) protocol 9405..
Blood.
259A-259A.
2005
-
A single cell analysis of immunoglobulin genes in chronic lymphocytic leukemia (CLL): Evidence of intraclonal diversification associated with progressive somatic mutations and progressive antigen drive in immunoglobulin heavy and light chains.
Blood.
346A-347A.
2005
-
ADAMTS13 levels support hypothesis of distinct mechanistic pathways for early versus late-onset of thienopyridine-associated thrombotic thrombocytopenic purpura (TTP)..
Blood.
22A-22A.
2005
-
Adhesive characteristics of hemoglobin SC red blood cells..
Blood.
23B-24B.
2005
-
Antigen-specific T lymphocyte function following unrelated cord blood transplantation (UCBT)..
Blood.
849A-849A.
2005
-
CD26 inhibition enhances allogeneic donor cell homing and engraftment after in utero bone marrow transplantation..
Blood.
371A-371A.
2005
-
Clinical and genetic profiles of the aging sickle cell patient..
Blood.
26A-26A.
2005
-
Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV..
Blood.
120A-120A.
2005
-
Delayed wound healing in hemophilia B mice..
Blood.
894A-894A.
2005
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia (ALL) - Cancer and leukemia group B study 9511.
Blood.
519A-519A.
2005
-
Erythropoietin and erythropoietin receptor expression in early stage non-small cell lung cancer: Prognostic significance..
Blood.
145B-145B.
2005
-
Ex vivo expansion of umbilical cord blood T cells for adoptive immunotherapy..
Blood.
15A-15A.
2005
-
Gene expression patterns identify novel biologically relevant signaling and transcriptional pathways involved in terminal erythroid differentiation and polycythemia vera.
Blood.
984A-984A.
2005
-
Incident TTP: Plasmapheresis therapy-related complications are common..
Blood.
365A-365A.
2005
-
Induction of chronic lymphocytic leukemia (CLL) apoptosis by nitric oxide synthase (NOS) inhibitors: Drug efficacy correlates with lipid solubility and NOS1 dissociation constant..
Blood.
342B-343B.
2005
-
Left sided heart dysfunction in sickle cell disease: Echocardiographic and genetic studies..
Blood.
27A-27A.
2005
-
Morbidity and associated sudden death in sickle cell disease..
Blood.
661A-661A.
2005
-
Multimodal dose dense therapy for mantle cell lymphoma..
Blood.
463B-463B.
2005
-
Partially HLA matched, non-myeloablative allogeneic transplantation.
Blood.
812A-812A.
2005
-
Pathogenic role of surface platelet factor 4 complexes in heparin-induced thrombocytopenia: Diagnostic and therapeutic implications..
Blood.
21A-21A.
2005
-
Predictors of survival in CLL: Multivariate analyses reveal significant correlation with IgV(H) gene mutation status, clinical stage, and cellular CD38 (but not Zap-70) expression..
Blood.
334B-334B.
2005
-
Priapism in SCD: Clinical and genetic correlations..
Blood.
887A-887A.
2005
-
Rapid in vivo acquisition of effector Tc1 phenotype even before myeloid engraftment predicts opportunistic infections (OI) in unrelated cord blood transplant recipients..
Blood.
409A-409A.
2005
-
Reaction of fibrinogen with homocysteine thiolactone mimics the dysfibrinogenemia produced by hyperhomocysteinemia..
Blood.
44A-44A.
2005
-
Role of LW and AKAP79 in beta-adrenergic receptor signaling-induced sickle red blood cell adhesion..
Blood.
889A-889A.
2005
-
Sodium orthovanadate (NaV) effects CD22 expression, intracellular signaling, and lymphomacidal activity of the HB22.7 anti-CD22 monoclonal antibody..
Blood.
428A-428A.
2005
-
The relationship of plasma laminin levels to anemia and the effect of soluble laminin on sickle red cell adhesion in SCD..
Blood.
657A-657A.
2005
-
Thrombotic and hemorrhagic events for patients on pediatric oncology group (POG) protocols 9201, 9605, 9406..
Blood.
258A-259A.
2005
-
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin..
Blood.
164A-164A.
2005
-
CALGB 59901: Results of a phase II study of 506U78 in CTCL and PTCL..
Blood.
682A-682A.
2004
-
Characterization of autoantibodies to PF4/heparin in a rat model of cardiopulmonary bypass..
Blood.
825A-825A.
2004
-
Cord blood (CB) bank log CD34(+) and CD34(+) subsets (CD38(-)CD61(+)CD90(+)) are significantly correlated to log total CFU, CFU-GEMM, CFU-GM and BFU-E: A report from the COBLT program.
Blood.
119A-119A.
2004
-
Dose dense, high intensity therapy in newly diagnosed elderly patients with acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg (TM)) and high dose cytarabine (HiDAC)..
Blood.
212B-213B.
2004
-
Ex vivo gene therapy of a preadolescent with x-linked severe combined immunodeficiency.
Blood.
120A-120A.
2004
-
FLT3 signaling is not necessary to the leukemogenic properties of MLL fusion genes in a marine model..
Blood.
706A-706A.
2004
-
Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial.
Blood.
210B-210B.
2004
-
Heparin-induced thrombocytopenia is a thymus (T cell) dependent disorder..
Blood.
825A-825A.
2004
-
Human memory T cells proliferate but do not elicit cytotoxicity in response to alloantigens..
Blood.
347A-347A.
2004
-
Pharmacogenetics of minimal residual disease response in children with acute lymphoblastic leukemia (ALL)..
Blood.
132A-132A.
2004
-
Promotion of stem cell-derived new T cell generation by CD62L-memory T cells requires alloantigen recognition..
Blood.
831A-831A.
2004
-
Recryopreserved and rethawed aliquots with anti-CD3, IL-2, IL12 significantly expands NKT cells, NKT KIR substes and NK cytotoxicity compared to short-term expansion: Potential for CB adoptive cellular immunotherapy (ACI)..
Blood.
778A-778A.
2004
-
The association of an early hemoglobin response with alternative metrics to evaluate treatment efficacy of erythropoietic agents..
Blood.
71A-71A.
2004
-
The use of DT388-IL3 fusion protein in patients with refractory acute myeloid leukemia(AML).
Blood.
212B-212B.
2004
-
A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase..
Blood.
252A-252A.
2003
-
A novel method for ex-vivo expansion of NKCD3-/CD16+/56(+bright/dim) subjects expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved (CTECT) umbilical cord blood (UCB) using anti-CD3, IL-2, IL-7, and IL-12 (AB/CY): Implications for adoptive cellular immunotherapy (ACI) post umbilical cord blood transplantation (UCBT).
Blood.
963A-964A.
2003
-
A single cell analysis of immunoglobulin genes in chronic lymphocytic leukemia (CLL): Progressive somatic mutations in the immunoglobulin heavy and light chains contribute to intraclonal diversification in CLL..
Blood.
666A-666A.
2003
-
Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study..
Blood.
226A-226A.
2003
-
B-CAM/LU polymorphisms: Effect on sickle cell disease outcomes and cell adhesion..
Blood.
28B-28B.
2003
-
Bronchiolitis obliterans organizing pneumonia (BOOP) after bone marrow transplantation (BMT) for sickle cell disease (SCD): Association with acute chest syndrome (ACS)..
Blood.
460B-461B.
2003
-
Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells..
Blood.
180B-180B.
2003
-
Chronic lymphocytic leukemia cells (CLL) express the neuronal isoform of nitric oxide synthase (NOS1), and NOS1-specific inhibitors induce CLL cell death..
Blood.
353B-353B.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings..
Blood.
238A-239A.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells..
Blood.
482A-482A.
2003
-
Clopidogrel-associated TTP: Comparison of quality and timeliness of case reports obtained from the FDA, the pharmaceutical supplier, and from active pharmacovigilance..
Blood.
496A-497A.
2003
-
Clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Clinical characteristics and predictors of survival..
Blood.
539A-539A.
2003
-
Combined infusion of peripheral blood stem cells (PBSC) plus bone marrow (BM) in poorly mobilizing patients undergoing high-dose therapy (HDT) and autologous stem cell transplant (ASCT).
Blood.
988A-989A.
2003
-
Complement-mediated hemolysis of erythrocytes is blocked by RNA aptamers to complement components C5 and C8..
Blood.
510A-510A.
2003
-
Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study..
Blood.
193A-193A.
2003
-
Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma..
Blood.
287B-287B.
2003
-
Ex vivo expansion of umbilical cord blood (UCB) derived immature and mature T cells..
Blood.
965A-965A.
2003
-
Examination of a VCAM1 polymorphism as a risk modifier for clinical outcomes in sickle cell disease..
Blood.
29B-29B.
2003
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation..
Blood.
396B-396B.
2003
-
In vitro exposure to epinephrine causes in vivo adhesion of human sickle red blood cells to vascular endothelium in nude mice: A new model for studying vaso-occlusion..
Blood.
261A-261A.
2003
-
Incidence, characteristics, and treatment of DVT in pregnant and postpartum women from the DVT FREE registry..
Blood.
808A-808A.
2003
-
Isolation of oligodendrocyte precursors from umbilical cord blood..
Blood.
965A-966A.
2003
-
Low-dose weekly paclitaxel for relapsed or refractory aggressive non-Hodgkins lymphoma..
Blood.
641A-641A.
2003
-
One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3-5/6 HLA matched related donors..
Blood.
476B-477B.
2003
-
Outcomes of 138 adult and pediatric patients undergoing cord blood transplantation from large cord blood bank..
Blood.
479A-479A.
2003
-
Pharmacokinetics of subcutaneous alemtuzumab in a patient with myeloma..
Blood.
385B-385B.
2003
-
Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma..
Blood.
635A-636A.
2003
-
Phase one evaluation of gemcitabine, fludarabine, and mitoxantrone for relapsed or refractory leukemia..
Blood.
250B-250B.
2003
-
Platelet transmission electron microscopy in genetically confirmed MYH9-related disorders..
Blood.
788A-789A.
2003
-
Platelets stimulated with convulxin plus thrombin develop platelet subpopulations with increased binding of factor VIII, factor IX, and factor X..
Blood.
293A-293A.
2003
-
Preliminary results of unrelated umbilical cord blood transplantation for Sanfilippo syndrome (MPS III)..
Blood.
481A-481A.
2003
-
Protein phosphatase inhibitors as potent cytotoxic agents for B-cell CLL in vitro..
Blood.
360B-360B.
2003
-
Results of the cord blood transplantation study (COBLT) unrelated donor banking program from donor screening to characterization of banked units..
Blood.
461A-461A.
2003
-
Risk assessment for hepatic veno-occlusive disease in patients treated with gemtuzumab ozogamicin (Mylotarg (R)) with or without hematopoietic stem cell transplantation..
Blood.
871A-871A.
2003
-
Sickle RBCs form microaggregates in autologous plasma following epinephrine stimulation: A role for endogenous, soluble laminin..
Blood.
82A-82A.
2003
-
Splenectomy prior to umbilical cord blood (UCB) transplantation facilitates hematologic engraftment in pediatric and adult patients..
Blood.
470A-471A.
2003
-
Successful treatment of pure red cell aplasia (PRCA) with alemtuzumab (CAMPATH-1H)..
Blood.
19B-19B.
2003
-
TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials..
Blood.
961A-961A.
2003
-
The interaction of platelets and endothelial cells modulates the procoagulant/anticoagulant balance in heparin-induced thrombocytopenia..
Blood.
805A-805A.
2003
-
The small GTPase rapl activates BCAM/LU-dependent but not alpha 4 beta l-dependent adhesion in sickle red blood cells: Evidence for divergent adhesive pathways..
Blood.
82A-82A.
2003
-
Thrombocytopenia is common among patients treated with heparin and is rarely detected and evaluated with serologic testing and hematology consultation: Preliminary findings from the CATCH registry..
Blood.
537A-537A.
2003
-
Umbilical cord blood cells engraft and differentiate in cardiac tissues after human transplantation..
Blood.
153B-153B.
2003
-
Unrelated donor umbilical cord blood transplantation for X-linked adrenoleukodystrophy..
Blood.
479B-479B.
2003
-
cAMP-dependent activation of sickle red blood cell adhesion is associated with LW serine and tyrosine phosphorylation..
Blood.
263A-263A.
2003
-
Ability of minority patients to find donors from an ethnically diverse cord blood bank..
Blood.
640A-641A.
2002
-
Anti-CD3/IL-2/IL-7/IL-12 ex-vivo expansion of previously cryopreserved and subsequent recryopreservation of umbilical cord blood (UCB) cytotoxic T lymphocytes: A new procedure for adoptive cellular immunotherapy (ACI) post UCB transplant (T)..
Blood.
58A-58A.
2002
-
B-CAM/LU mediates laminin-independent cell-cell adhesion under both static and flow conditions..
Blood.
451A-451A.
2002
-
Campath-1H, T cell depleted nonmyeloablative peripheral blood stem cell transplantation from 3-6/6 HLA matched family members..
Blood.
638A-638A.
2002
-
Chronic lymphocytic leukemia (CLL) cell CD38 expression and inducible nitric oxide synthase (NOS2) expression are associated with serum IL-4 levels..
Blood.
357B-357B.
2002
-
Clinical evaluation of retroviral vectors for corrective gene transfer of adenosine deaminase (ADA) deficiency..
Blood.
116A-116A.
2002
-
Correction of congenital immunodeficiency disease with umbilical cord blood transplantation..
Blood.
858A-858A.
2002
-
Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT)..
Blood.
112A-112A.
2002
-
Donor chimerism after T-Cell depleted (TCD)-Non-Myeloablative allogeneic SCT (NST) in hemoglobinopathies..
Blood.
401B-402B.
2002
-
Donor-specific tolerance after hematopoietic reconstitution with Campath-1H treated mobilized peripheral blood cells in a sublethal preconditioning regimen..
Blood.
410A-410A.
2002
-
Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children..
Blood.
841A-841A.
2002
-
Elevated expression of numerous interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis..
Blood.
584A-584A.
2002
-
Ex vivo expansion of CB derived AC 133 progenitor cells with a polyamine copper chelator: Pre-clinical data..
Blood.
419B-419B.
2002
-
Ex vivo propagation and expansion of umbilical cord blood derived immature and mature T-cells..
Blood.
833A-833A.
2002
-
Failure of a minimally toxic non-myeloablative regimen to establish stable donor engraftment after transplantation for sickle cell anemia and beta-thalassemia..
Blood.
46A-46A.
2002
-
Fatal rapidly progressive liver disease associated to a novel mutation of the perforin gene..
Blood.
466A-466A.
2002
-
Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin..
Blood.
339A-339A.
2002
-
Gene expression profiling of AAV serotype 1-5 vectors in adult and neonatal animals using in vivo bioluminescence imaging..
Blood.
220A-220A.
2002
-
Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells..
Blood.
867A-867A.
2002
-
Immunophenotypic and functional characterization of CD4+ CD25+ regulatory T cells as a function of aging in normal human peripheral blood and autoimmune disease..
Blood.
250A-250A.
2002
-
In vitro priming and generation of cytomegalovirus-specific T cell responses from umbilical cord blood..
Blood.
54B-55B.
2002
-
In vivo engraftment and differentiation of murine adipose derived stromal cells..
Blood.
731A-731A.
2002
-
Intracellular inositol polyphosphatides signaling via factor VIIa and factor X: The possible role of protease-activated receptor 2 and tissue factor activation..
Blood.
69B-69B.
2002
-
Modulation by epinephrine of PKA-dependent signaling pathways in sickle red blood cells induces activation of LW binding to endothelial cell alpha v beta 3 integrin..
Blood.
118A-118A.
2002
-
Morpholino antisense oligomer to integrin alpha, inhibits angiogenesis in a mouse model of retinopathy of prematurity..
Blood.
680A-680A.
2002
-
Nucleated cell count and CD34+count similar between cord blood units collected from Caucasian and non Caucasian umbilical cord blood donors..
Blood.
618A-618A.
2002
-
Philadelphia-chromosome (Ph+) acute lymphoblastic leukemia (ALL) in children and adolescents: Outcome with unrelated placental cord blood (PCB) transplantation..
Blood.
856A-856A.
2002
-
Preliminary analysis of a randomized phase 2 study of the safety and efficacy of 1 vs. 2 doses of gemtuzumab ozogamicin (Mylotarg (R)) in patients with high risk myelodysplastic syndrome..
Blood.
795A-795A.
2002
-
Racial/ethnic diversity achieved in national network of cord blood banks..
Blood.
186A-186A.
2002
-
Relationship of sickle red blood cell laminin binding to disease activity..
Blood.
450A-451A.
2002
-
Successful treatment of lymphoma xenografts with the anti-CD22 mAb HB22.7 alone and augmented response when given with Y90-DOTA-PEPTIDE-LYM-1 that is sequence specific..
Blood.
315B-315B.
2002
-
Three methods of T-cell depletion of HPCT products: Analysis of CD34+ cell and lymphocyte purity and recovery..
Blood.
835A-836A.
2002
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up..
Blood.
864A-864A.
2002
-
Treatment of severe systemic sclerosis with allogenic marrow transplantation..
Blood.
460B-461B.
2002
-
Unrelated umbilical cord blood (UCB) transplantation for infants with acute lymphoblastic leukemia (ALL) and rearrangements of the 11q23 chromosomal region..
Blood.
855A-856A.
2002
-
Unrelated umbilical cord blood transplant for Wiskott-Aldrich syndrome..
Blood.
855A-855A.
2002
-
Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): Impact on CNS disease..
Blood.
45A-46A.
2002
-
Within-trial resource utilization and costs of patients randomized to treatment with imatinib (STI571) versus interferon-alpha (IFN-alpha) combined with cytarabine (Ara-C) in newly diagnosed patients with chronic myeloid leukemia in chronic phase..
Blood.
187A-187A.
2002
-
Effect of hyperhomocysteinemia on protein C activation and activity in vivo..
Blood.
257A-258A.
2001
-
Enumerating functionally mature monocyte-derived dendritic cells for use in cancer immunotherapy..
Blood.
851A-851A.
2001
-
High dose factor VIIa enhances clot stability in a model of hemophilia..
Blood.
826A-827A.
2001
-
Quantitating antigen specific T cell responses in peripheral blood: A comparison of peptide MHC tetramer, ELISpot and intracellular cytokine analysis..
Blood.
23A-23A.
2001
-
Addition of stem cells from allogeneic donors accelerates engraftment and immune reconstitution after stem cell transplantation..
Blood.
172A-172A.
2000
-
Dendritic cell (DC) reconstitution after non-myeloablative allogeneic stem cell transplants..
Blood.
305B-305B.
2000
-
Hematopoiteic stem cell doses correlate with the speed of immune reconstitution after allogeneic stem cell transplantation..
Blood.
772A-772A.
2000
-
Hyperhomocysteinemia induces alterations in fibrinogen function and fibrin clot structure in a rabbit model..
Blood.
39A-39A.
2000
-
Hyperhomocysteinemia induces monocyte tissue factor (TF) expression in vivo..
Blood.
32B-32B.
2000
-
Multiple signals are required for IL-12 production by Flt-3 ligand mobilized dendritic cells..
Blood.
295A-295A.
2000
-
Prolonged disease-free survival in patients with acute myeloid leukemia in first relapse treated with gemtuzumab ozogamicin (Mylotarg (TM), CMA-676) followed by hematopoietic stem cell transplantation..
Blood.
320A-320A.
2000
-
V beta repertoire of T lymphocytes emerging in adults after unrelated umbilical cord blood (UCB) allogeneic transplantation..
Blood.
788A-788A.
2000
-
Activated protein C (APC) functions by inhibiting initiation of coagulation rather than by terminating a hemostatic response..
Blood.
224A-224A.
1999
-
De-encryption of cellular tissue factor is independent of its cytoplasmic domain..
Blood.
227A-227A.
1999
-
Efficacy and safety of CMA-676 in patients with AML in first relapse..
Blood.
696A-696A.
1999
-
FLT3-ligand (FLT3L) mobilization of dendritic cells (DC) in patients with metastatic colon cancer..
Blood.
48A-48A.
1999
-
Impaired immune function in murine adult cord blood recipients..
Blood.
568A-568A.
1999
-
Reconstitution of the immunohematopoietic system in adult murine recipients across major histocompatibility complex by near-term fetal blood..
Blood.
321A-321A.
1999
-
Residual trisomic cells in a patient with resolving transient myeloproliferative disorder and trisomy 21 mosaicism..
Blood.
291B-291B.
1999
-
The initial rate, but not the total amount, of thrombin (IIa) generated determines fibrin clot structure in a cell-based model of coagulation..
Blood.
230A-231A.
1999
-
Tissue factor independent effect of high dose factor VIIa directly correlates with factor X levels..
Blood.
228A-228A.
1999